Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines, today announced that the Company has successfully completed a pre-clinical proof-of-concept ...

Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says Catalent’s Nathan Bennette at AAPS PharmSci ...